Polymerase (RNA) II (DNA directed) polypeptide A (RPB1) is the largest subunit of RNA polymerase II (RNAPII), and phosphorylation of its C-terminal domain (CTD) is required for transcription initiation, elongation and RNA processing. Little is known about the CTD phosphorylation pattern and potential function during cell division when transcription is silenced. In this study, we assessed the protein expression and subcellular distribution of RPB1 during mouse oocyte meiotic division. Western blot analysis revealed that the RPB1 CTD was highly phosphorylated on Ser2 (pRPB1(Ser2)), Ser5 (pRPB1(Ser5)) and Ser7 (pRPB1(Ser7)). High and stable expression of pRPB1(Ser2) and pRPB1(Ser5) was detected from germinal vesicle (GV) to Metaphase II (MII) stage. In contrast, pRPB1(Ser7) only emerged after germinal vesicle breakdown (GVBD) and gradually increased to its peak level at metaphase I (MI) and MII. Immunofluorescence demonstrated that pRPB1(Ser2), pRPB1(Ser5) and pRPB1(Ser7) were pronouncedly aggregated within the nucleus of GV oocytes with a non-surrounded nucleolus (NSN) but very faintly labeled in oocytes with a surrounded nucleolus (SN). After meiotic resumption, pRPB1(Ser2) was again detected at spindle poles and co-localized with key microtubule organizing center (MTOC) components, pericentrin and γ-tubulin. pRPB1(Ser5) and pRPB1(Ser7) were assembled as filamentous aggregates and co-localized with microtubules throughout the spindle structure, responding to spindle-disturbing drugs, nocodazole or taxol, in pattern strongly similar to microtubules. pRPB1(Ser2) and pRPB1(Ser5) were constantly localized on chromosomes, with a relatively high concentration in centromere areas. Taken together, our data suggest that the CTD is highly phosphorylated and may be required for accurate chromosome segregation in mouse oocytes during meiosis.
Polymerase (RNA) II (DNA directed) polypeptide A (RPB1) is the largest subunit of RNA polymerase II (RNAPII), and phosphorylation of its C-terminal domain (CTD) is required for transcription initiation, elongation and RNA processing. Little is known about the CTD phosphorylation pattern and potential function during cell division when transcription is silenced. In this study, we assessed the protein expression and subcellular distribution of RPB1 during mouse oocyte meiotic division. Western blot analysis revealed that the RPB1 CTD was highly phosphorylated on Ser2 (pRPB1(Ser2)), Ser5 (pRPB1(Ser5)) and Ser7 (pRPB1(Ser7)). High and stable expression of pRPB1(Ser2) and pRPB1(Ser5) was detected from germinal vesicle (GV) to Metaphase II (MII) stage. In contrast, pRPB1(Ser7) only emerged after germinal vesicle breakdown (GVBD) and gradually increased to its peak level at metaphase I (MI) and MII. Immunofluorescence demonstrated that pRPB1(Ser2), pRPB1(Ser5) and pRPB1(Ser7) were pronouncedly aggregated within the nucleus of GV oocytes with a non-surrounded nucleolus (NSN) but very faintly labeled in oocytes with a surrounded nucleolus (SN). After meiotic resumption, pRPB1(Ser2) was again detected at spindle poles and co-localized with key microtubule organizing center (MTOC) components, pericentrin and γ-tubulin. pRPB1(Ser5) and pRPB1(Ser7) were assembled as filamentous aggregates and co-localized with microtubules throughout the spindle structure, responding to spindle-disturbing drugs, nocodazole or taxol, in pattern strongly similar to microtubules. pRPB1(Ser2) and pRPB1(Ser5) were constantly localized on chromosomes, with a relatively high concentration in centromere areas. Taken together, our data suggest that the CTD is highly phosphorylated and may be required for accurate chromosome segregation in mouse oocytes during meiosis.
In somatic cells, transcription activity is silenced as chromatin is condensed when the cell cycle progresses to
mitosis and is reactivated when the cells enter the next Gap I (G1) phase after mitosis completion. Similarly, in
mammalian oocytes, genome transcription is shut down upon resumption of meiosis, remaining quiescent during the
following meiotic progression and even several cycles of early cleavage after fertilization [1, 2]. Transcription is driven by a dynamic functional
complex composed of RNA polymerase and various regulating factors, and this complex is detached from DNA when the
transcription process is arrested during mitosis or meiosis; however, but its form, distribution and possible
function are not yet entirely clear.Up to now, only a few studies have been carried out to explore the expression and potential function of
transcription factors during cell division. Transcription factor II H (TFIIH), a general transcription factor, is
required for the formation of the RNA polymerase II (RNAPII) pre-initiation complex [3]. Two subunits of TFIIH, XPD (Xeroderma pigmentosum D ortholog) and XPB (Xeroderma pigmentosum
B ortholog), are localized to the mitotic spindle during mitosis and required for proper chromosome segregation
[4,5,6]. Early growth response 3 (Egr3), a transcription factor, has recently been verified to be a
microtubule organizing center (MTOC)-associated protein in mouse oocytes, and it might play a role during meiotic
spindle formation [7]. This evidence suggests transcription-associated
factors may play a role in molecular mechanisms governing chromosome separation during transcription silencing,
yet whether such an involvement is a universal feature for other transcription factors requires further study.Polymerase (RNA) II (DNA directed) polypeptide A (RPB1) is the largest and catalytic subunit of RNAP II and
contains a carboxy terminal domain (CTD) composed of 52 heptapeptide repeats of
Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7, essential for polymerase activity [8].
CTD phosphorylation at Ser5 is required for transcriptional initiation [9],
Ser7 phosphorylation is essential for transcription elongation [10] and
Ser2 phosphorylation plays a critical role in mRNA 3’-end processing, splicing, transcriptional elongation and
termination factor recruitment to RNAP II in vivo [9, 11]. Other modifications, including phosphorylation of Tyr1 and Thr4, also
contribute to CTD functions during transcription [12, 13]. Therefore, CTD phosphorylation exerts a central role in transcription initiation and
orderly completion. Whether or not CTD phosphorylation occurs in mitotic or meiotic cells is rarely investigated.
Abe et al. (2010) reported that CTD is dephosphorylated in mouse oocytes approaching meiotic
resumption [14]. An early investigation showed that CTD is obviously
phosphorylated after resumption of meiosis and dephosphorylated upon the completion of meiosis after fertilization
in Xenopus oocytes [15]. It has not yet been determined which amino acid
residues are phosphorylated in CTD sequence nor have the intracellular localization and potential function of RPB1
been determined in relation to the phosphorylated CTD during cell division.In the present study, RPB1 was found to be highly phosphorylated on Ser2, Ser5 and Ser7 in the CTD sequence in
mouse oocytes during meiosis. Phosphorylated RPB1s were localized to the MTOC, spindle microtubules and chromosome
centromeres, implying a possible involvement of CTD phosphorylation in meiotic spindle formation and chromosome
segregation during oocyte meiotic division.
Materials and Methods
Oocyte collection and culture
All experimental procedures were carried out in accordance with the policies for the Care and Use of Animals
in Research and Teaching and approved by the Animal Care Commission of Capital Medical University. The oocytes
were obtained from CB6F1 (female BALB/C × male C57BL/6) mice. Twenty-one-day-old females were euthanized with
CO2 44–48 h after injection with 10 IU of pregnant mare serum gonadotropin (PMSG) (Beijing
XinHuiZeAo Science and Technology), and cumulus-oocyte complexes (COCs) were harvested from ovaries and
cultured in Minimal Essential Medium (MEM) with 3 mg/ml bovineserum albumin (BSA, Sigma) and 10% fetal bovine
serum (FBS, Gibco, Grand Island, NY, USA) at 37 C in an incubator with 5% CO2 and 100% humidity.
Oocytes at the germinal vesicle (GV), germinal vesicle breakdown (GVBD), prometaphase I (pro-MI), metaphase I
(MI) and metaphase II (MII) stages of meiosis were obtained after cultures of 0, 2, 4, 8 and 17 h,
respectively. After appropriate culture, oocytes were collected for further drug treatment experiments or
immunofluorescence staining and western blot analysis.
Immunofluorescence analysis
Oocytes were fixed in 2% paraformaldehyde with 0.5% Triton X-100 in PEM Buffer (100 mM Pipes, pH 6.9, 1 mM
MgCl2, 1 mM EGTA) for 45 min at room temperature. After being washed three times in
phosphate-buffered saline (PBS) with 0.2% Triton X-100 (PBST) for 5 min each, the oocytes were blocked in 10%
normal goat serum in PBS for 1 h at room temperature and then incubated in diluted primary antibodies: rabbit
anti-RPB1(1:200, Novus, Littleton, CO, USA), rabbit anti-RNA polymerase II CTD repeat YSPTSPS (phospho Ser2)
(1:500, Abcam, Hong Kong, China), rabbit anti-RNA polymerase II CTD repeat YSPTSPS (phospho Ser5) (1:1000,
Abcam), rabbit anti-RNA polymerase II subunit B1 (phosphor-CTD Ser7) (1:250, Millipore, Temecula, CA, USA),
mouse anti-acetylated tubulin (1:10000, Sigma, St. Louis, MO, USA), mouse anti-γ-tubulin (1:1000, Sigma) and
mouse anti-pericentrin (1:3000, BD Transduction Laboratories, San Jose, CA, USA). After being washed in PBST,
the oocytes were labeled with secondary antibodies for 45 min at room temperature and then mounted on
microscope slides in mounting medium with DAPI (Vector Laboratories, Burlingame, CA, USA) and examined with a
fluorescent microscope (Olympus Microsystems, Tokyo, Japan). A negative control was included to demonstrate
the specificity of the primary antibodies used above, and oocyte samples were processed for the immunostaining
procedure with no primary antibody incubation.In order to determine the accurate localization of phosphorylated RPB1 on chromosomes, immunofluorescence was
carried out on oocyte chromosome spreads as previously reported [16].
Briefly, the denuded oocytes were incubated in acid Tyrode’s solution (Sigma) at 37 C for 2 min to eliminate
the zona pellucida and then recovered in MEM/BSA at 37 C within a short time. The oocytes were transferred
onto glass slides and fixed in 1% paraformaldehyde with 0.1% Triton X-100. The air-dried slides were stored at
–20 C for future use. Prior to immunolabeling, the slides were thoroughly washed in a sufficient volume of PBS
to remove excess salts. The chromosome samples were incubated in primary antibody solution: Centromere
antiserum (1:1000, Fitzgerald, Acton, MA, USA), anti-RNA polymerase II CTD repeat YSPTSPS (phospho Ser2)
(1:500, Abcam) or anti-RNA polymerase II CTD repeat YSPTSPS (phospho Ser5) (1:500, Abcam) at 4 C overnight and
then visualized with fluorescein-labeled goat anti-human and goat anti-rabbit IgG. Chromosomes were
counterstained with DAPI in mounting medium (Vector Laboratories) and then assessed with a fluorescent
microscope (Olympus Microsystems).
Western blot analysis
A total of 100 oocytes were collected in Laemmli Sample Buffer (Bio-Rad, Hercules, CA, USA) with protease
inhibitor cocktail (Sigma) and stored at –80 C. Prior to analysis, the samples were thawed and heated at 100 C
for 5 min. The proteins were separated by SDS-PAGE on 7.5% polyacrylamide gel with 0.1% SDS and electroblotted
onto polyvinylidene fluoride membranes (PVDF) (Amersham Biosciences, Buckinghamshire, UK). After blocking in
1% BSA in Tris-buffered saline (TBS) with 0.1% Tween-20 (TBST) at 4 C overnight, the membranes were incubated
at 37 C for 2 h with diluted primary antibodies, including rabbit anti-RPB1 antibody (1:250, Novus), rabbit
anti-RNA polymerase II CTD repeat YSPTSPS (phospho Ser2) (1:500, Abcam), rabbit anti-RNA polymerase II CTD
repeat YSPTSPS (phospho Ser5) (1:2000, Abcam) and rat anti-RNA polymerase II subunit B1 (phosphor-CTD Ser7)
(1:100, Millipore), and thereafter, they were thoroughly washed in TBST and incubated in peroxidase-conjugated
secondary antibodies (ZSGB-BIO, Beijing, China) for 1 h at room temperature. The protein bands on membranes
were visualized with enhanced chemiluminescence detection reagents (Applygen Technologies Inc, Beijing,
China), according to the manufacturer’s protocol.
Treatment with nocodazole and taxol
Nocodazole is a microtubule depolymerization agent, and taxol is a microtubule stabilizer. The stock solution
of nocodazole (Sigma) was prepared at a concentration of 20 mM in dimethyl sulfoxide (DMSO, Sigma), and taxol
(Sigma) stock solution was made at a concentration of 10 mM in DMSO. Just before use, the stock solutions were
diluted to suitable concentrations in culture medium. The final concentration of DMSO in the medium was not
more than 0.1% (v/v). For nocodazole treatment, MI-stage oocytes were incubated in MEM/BSA containing 10 μM
nocodazole for 5, 10 or 15 min at 37 C in an atmosphere of 5% CO2 in air. For taxol treatment, the
oocytes were treated with 10 μM taxol in MEM/BSA for 45 min. Control oocytes were incubated in MEM/BSA
supplemented with the same concentration of DMSO. After drug treatment, the oocytes were fixed for
immunofluorescence analysis.
Results
CTD phosphorylation on Ser2, Ser5 and Ser7 occurred in mouse oocytes during meiotic division
To explore whether RPB1 CTD is phosphorylated in oocytes during meiotic division, western blot analysis was
conducted in mouse oocytes at the GV, GVBD, MI and MII stages. As shown in Fig. 1, CTD phosphorylation on Ser2 (pRPB1Ser2), Ser5 (pRPB1Ser5) and Ser7
(pRPB1Ser7) was obviously detected in meiotic oocytes. In brief, stable expression of
pRPB1Ser2 and pRPB1Ser5 was consistently probed from the GV to MII stage. In contrast,
pRPB1Ser7 was very faintly detected at the GV stage but increased gradually from GVBD and reach
its peak level in MI and MII. As an additional control, the level of total RPB1 was detected in stable level
throughout meiosis. These data strongly indicate RNAP II CTD phosphorylation definitely occurs in mammalian
oocytes after meiotic resumption and that such modification is not required for transcription but might be
involved in meiotic cycle regulation.
Fig. 1.
Protein expression of RPB1, pRPB1Ser2, pRPB1Ser5 and pRPB1Ser7 in
mouse oocytes during meiotic division. Western blot analysis showed the protein levels of RPB1 and
phosphorylated RPB1s in oocytes during meiotic maturation. The experiments were repeated at least three
times.
Protein expression of RPB1, pRPB1Ser2, pRPB1Ser5 and pRPB1Ser7 in
mouse oocytes during meiotic division. Western blot analysis showed the protein levels of RPB1 and
phosphorylated RPB1s in oocytes during meiotic maturation. The experiments were repeated at least three
times.
RPB1 was uniformly distributed throughout the cytoplasm after GVBD
As shown in Fig. 2, the intracellular distribution of RPB1 was largely confined inside the enlarged nucleus when the
nuclear envelope was intact at the GV stage, and no special accumulation of RPB1 was labeled in the cytoplasm.
Notably, RPB1 accumulation was rarely observed in nuclei with a nucleolus surrounded by a rim of DAPI-positive
chromatin (surrounded nucleolus, SN) (Fig.2, a’: arrow); it was
mainly labeled in nuclei without such a chromatin rim around the nucleolus (non-surrounded nucleolus, NSN)
(Fig.2, c: arrow). This is consistent with the fact that no
transcriptional activity was detected in the SN-type oocytes [17].
Obviously, no fluorescence signal of RPB1 was detected in negative control oocytes (Supplementary Fig. 1, A: online only). With oocyte progression from
the GVBD to MII stage, RPB1 was uniformly distributed throughout the cytoplasm, unequivocally, and no
fluorescent signal was labeled on chromosomes or the spindle structure. It can be claimed that RPB1 protein
was transferred from the nucleus to the cytoplasm and uniformly distributed in the oocyte upon resumption of
meiosis.
Fig. 2.
RPB1 subcellular distribution in mouse oocytes during meiosis. Immunocytochemical staining showed the
sub-cellular localization of RPB1 in oocytes at different stages of meiotic maturation. Scale bar = 20
μm. DNA was visualized in blue, RPB1 was visualized in red, and Ace-tubulin was visualized in green.
RPB1 was highly concentrated in the nucleus of NSN-type oocytes at the GV stage (c: arrow) but faintly
labeled in SN oocytes (a’: arrow). RPB1 was evenly distributed throughout the cytoplasm after meiotic
resumption, exhibiting no specific association with chromosomes and the spindle structure (e–x). The
arrowheads in u indicate the first polar body (1st PBD) in MII oocytes.
RPB1 subcellular distribution in mouse oocytes during meiosis. Immunocytochemical staining showed the
sub-cellular localization of RPB1 in oocytes at different stages of meiotic maturation. Scale bar = 20
μm. DNA was visualized in blue, RPB1 was visualized in red, and Ace-tubulin was visualized in green.
RPB1 was highly concentrated in the nucleus of NSN-type oocytes at the GV stage (c: arrow) but faintly
labeled in SN oocytes (a’: arrow). RPB1 was evenly distributed throughout the cytoplasm after meiotic
resumption, exhibiting no specific association with chromosomes and the spindle structure (e–x). The
arrowheads in u indicate the first polar body (1st PBD) in MII oocytes.
pRPB1Ser2 was concentrated in MTOCs and centromeres during meiotic division
Immunofluorescence clearly demonstrated that the subcellular distribution of phosphorylated RPB1s was
distinguishably different from that of unphosphorylated RPB1s and associated with cellular events responsible
for chromosomes separation. As shown in Fig. 3, pRPB1Ser2 was evenly distributed within the nucleus in NSN-type GV oocytes (Fig. 3, c: arrow); in contrast, it was only faintly labeled in SN-type
oocytes. Upon GVBD, pRPB1Ser2 emerged again as many small foci surrounding the condensing chromatin
(Fig. 3, g: arrow). These foci gradually fused and clustered into
two separate groups along with the meiotic progression from the GVBD to pro-MI stage (Fig. 3, k: arrow), and they finally concentrated on two separate poles of the spindle
formed at the MI stage (Fig. 3, o: arrow). Multiple distinct foci
were also labeled in other areas of the cytoplasm (Fig. 3, g:
asterisk). During anaphase I (AI)/telophase I (TI) transition, pRPB1Ser2 disappeared from the polar
area and cytoplasm but was localized to the midbody derived from the MI spindle. By the MII stage, a
barrel-shape spindle was formed, and pRPB1Ser2 was once again focused on the spindle poles (Fig. 3, w: arrow). Polar concentration of pRPB1Ser2 implies
it might be associated with MTOCs in oocytes. No special accumulation of pRPB1Ser2 was observed in
the negative control (Supplementary Fig. 1).
Fig. 3.
pRPB1Ser2 localization and its association with the spindle in mouse oocytes during meiotic
maturation. Immunofluorescence analysis showed the unique subcellular distribution pattern of
pRPB1Ser2 in oocytes during meiotic division. Scale bar = 20 μm. DNA was visualized in
blue, pRPB1Ser2 was visualized in red, and Ace-tubulin was visualized in green. Yellow
indicates the overlapping of pRPB1Ser2 and microtubules. A high concentration of
pRPB1Ser2 was confined within the nucleus of NSN-type oocytes (c: arrow), and no
aggregation was detected in SN oocytes (a’, b’, c’, d’). pRPB1Ser2 reappeared as many small
foci around condensing chromatin after GVBD (e–k). Highly concentrated pRPB1Ser2 was
localized on two opposite poles of the meiotic spindle at the MI and MII stages (m–p, u–x: arrow).
pRPB1Ser2 localization and its association with the spindle in mouse oocytes during meiotic
maturation. Immunofluorescence analysis showed the unique subcellular distribution pattern of
pRPB1Ser2 in oocytes during meiotic division. Scale bar = 20 μm. DNA was visualized in
blue, pRPB1Ser2 was visualized in red, and Ace-tubulin was visualized in green. Yellow
indicates the overlapping of pRPB1Ser2 and microtubules. A high concentration of
pRPB1Ser2 was confined within the nucleus of NSN-type oocytes (c: arrow), and no
aggregation was detected in SN oocytes (a’, b’, c’, d’). pRPB1Ser2 reappeared as many small
foci around condensing chromatin after GVBD (e–k). Highly concentrated pRPB1Ser2 was
localized on two opposite poles of the meiotic spindle at the MI and MII stages (m–p, u–x: arrow).Further immunocytochemistry was carried out to reveal the spatial relationship between pRPB1Ser2
and key components of the MTOC, γ-tubulin and pericentrin, in oocytes. As shown in Fig. 4A, pRPB1Ser2 was essentially co-localized with both γ-tubulin and pericentrin on spindle poles
(Fig. 4A: arrow), as well as in several cytoplasmic MTOCs (Fig. 4A: arrowhead) in MI oocytes. Actually, the tight colocalization of
pRPB1Ser2 with pericentrin and γ-tubulin was consistently observed from GVBD to MII (data not
shown). The data suggest that pRPB1Ser2 is a newly proved MTOC-associated protein and that it may
play a role in meiotic spindle formation through regulation of MTOC organization and maintenance.
Fig. 4.
A: Colocalization of pRPB1Ser2 with MTOC proteins in mouse oocytes. Immunofluorescence
analysis revealed colocalization of pRPB1Ser2 with the MTOC core components, γ-tubulin or
pericentrin. DNA was visualized in blue, pRPB1Ser2 was visualized in red, and γ-tubulin or
pericentrin was visualized in green. Scale bar = 20 μm. pRPB1Ser2 was specially co-localized
with γ-tubulin or pericentrin in the spindle polar area, as well as in some cytoplasmic MTOCs (b–d, f–h:
arrows). B: pRPB1Ser2 concentration on chromosome centromeres in mouse oocytes.
pRPB1Ser2 was visualized in red, CREST was visualized in green, and DNA was visualized in
blue. Scale bar = 10 μm. pRPB1Ser2 was persistently aggregated on the chromosome centromere
area in oocytes from the pro-MI to MII stage (b–c, f–h, k–m: arrows).
A: Colocalization of pRPB1Ser2 with MTOC proteins in mouse oocytes. Immunofluorescence
analysis revealed colocalization of pRPB1Ser2 with the MTOC core components, γ-tubulin or
pericentrin. DNA was visualized in blue, pRPB1Ser2 was visualized in red, and γ-tubulin or
pericentrin was visualized in green. Scale bar = 20 μm. pRPB1Ser2 was specially co-localized
with γ-tubulin or pericentrin in the spindle polar area, as well as in some cytoplasmic MTOCs (b–d, f–h:
arrows). B: pRPB1Ser2 concentration on chromosome centromeres in mouse oocytes.
pRPB1Ser2 was visualized in red, CREST was visualized in green, and DNA was visualized in
blue. Scale bar = 10 μm. pRPB1Ser2 was persistently aggregated on the chromosome centromere
area in oocytes from the pro-MI to MII stage (b–c, f–h, k–m: arrows).To determine the precise localization of pRPB1Ser2 on chromosomes, oocyte chromosome spreads were
prepared and immunolabeled with pRPB1Ser2 antibody and centromere autoantibody (CREST). As shown in
Fig. 4B, pRPB1Ser2 was especially concentrated as
bright dots on chromosome centromeres (Fig. 4B: arrow). It is
noteworthy that pRPB1Ser2 was persistently detected in the centromere area from the pro-MI to MI
stage and at the MII stage. No pRPB1Ser2 was labeled on the chromosome arm outside the centromere
region. The centromeric localization of pRPB1Ser2 implies that CTD phosphorylation might be
involved in the regulation of microtubules attaching to kinetochores in the centromere area.
pRPB1Ser5 was localized on spindles and chromosomes after GVBD
To determine the distribution pattern of pRPB1Ser5 during mouse oocyte meiotic division,
immunocytochemistry was carried out on wholly fixed oocytes and chromosome spreads. The overall subcellular
distribution of pRPB1Ser5 was different from that of pRPB1Ser2 (Fig. 5). In NSN-type GV oocytes, pRPB1Ser5 was mainly present as fine particles uniformly
distributed in the germinal vesicle (Fig. 5, c); at the same time,
it was also noted as a number of bright dots dispersed randomly within the nucleus. In SN oocytes,
pRPB1Ser5 accumulation almost disappeared, and only a few bright dots of different sizes were
detected in the region surrounding the nucleolus (Fig. 5, c’). After
GVBD, these pRPB1Ser5 foci were totally disassembled, reaggregated into filamentous bundles around
condensing chromatin and completely co-localized with microtubules, especially at the MI and MII stages (Fig. 5, e–x). pRPB1Ser5 was organized into bipolar structure
that was precisely overlapped with the spindle organized from microtubules (Fig. 5, n, o, p). No special organization of pRPB1Ser5 was found in oocytes without
primary antibody incubation (Supplementary Fig.
1).
Fig. 5.
pRPB1Ser5 subcellular distribution and its relationship with the spindle in oocytes during
meiotic division. Immunocytochemical analysis showed that pRPB1Ser5 was precisely colocalized
with microtubules on the spindle in oocytes during meiotic maturation. DNA was visualized in blue,
pRPB1Ser5 was visualized in red, and Ace-tubulin was visualized in green. Yellow indicates
the overlapping of pRPB1Ser5 and microtubules. Scale bar = 20 μm. At the GV stage,
pRPB1Ser5 was labeled in the nucleus of NSN-type oocytes (a–d) and almost undetectable in
SN oocytes, and only a few bright dots were detected around the nucleolus (a’ –d’). After GVBD,
pRPB1Ser5 was aggregated into filamentous bundles and completely co-localized with
microtubules, and it was shaped into a bipolar structure that was precisely overlapped by the meiotic
spindle at the MI and MII stages (m–p, u–x; arrowhead: 1st polar body).
pRPB1Ser5 subcellular distribution and its relationship with the spindle in oocytes during
meiotic division. Immunocytochemical analysis showed that pRPB1Ser5 was precisely colocalized
with microtubules on the spindle in oocytes during meiotic maturation. DNA was visualized in blue,
pRPB1Ser5 was visualized in red, and Ace-tubulin was visualized in green. Yellow indicates
the overlapping of pRPB1Ser5 and microtubules. Scale bar = 20 μm. At the GV stage,
pRPB1Ser5 was labeled in the nucleus of NSN-type oocytes (a–d) and almost undetectable in
SN oocytes, and only a few bright dots were detected around the nucleolus (a’ –d’). After GVBD,
pRPB1Ser5 was aggregated into filamentous bundles and completely co-localized with
microtubules, and it was shaped into a bipolar structure that was precisely overlapped by the meiotic
spindle at the MI and MII stages (m–p, u–x; arrowhead: 1st polar body).The morphological relationship between pRPB1Ser5 and microtubules was further confirmed using
spindle-perturbing drugs, nocodazole and taxol. Firstly, the MI oocytes were treated for 5, 10 and 15 min with
nocodazole, a microtubule-depolymerizing agent. As microtubules gradually depolymerized with the increase in
drug processing time, pRPB1Ser5 fibers also disassembled, but they always maintained colocalization
with microtubules (Fig. 6A, b and c: arrow head). Upon complete depolymerization of spindle microtubules, the filamentous
pRPB1Ser5 was also totally dismantled. In addition, despite the morphological change of
pRPB1Ser5 along with the spindle, the pRPB1Ser5 localization on chromosomes was
persisted during the entire process of nocodazole treatment (Fig. 6A,
g: arrowhead). Next, the MI oocytes were treated for 45 min with taxol, a microtubule-stabilizing
drug. As shown in Fig. 6A, taxol suppressed microtubule dynamics in
oocytes, thus causing excessive polymerization of microtubules and formation of astral microtubules in the
spindle architecture and numerous MTOCs in the cytoplasm. Interestingly, pRPB1Ser5 exhibited the
exactly same change pattern and was completely co-localized with microtubules in the spindle and cytoplasmic
MTOCs (Fig. 6A, j–l). These data clearly indicates that the
accumulation and distribution of pRPB1Ser5 were associated with the structural integrity of the
spindle in oocytes.
Fig. 6.
A: Changes of pRPB1Ser5 distribution in MI oocytes treated with spindle-disturbing agents.
pRPB1Ser5 always remained colocalized with microtubules as spindle integrity and
microtubule stability were altered with nocodazole (10 μM) and taxol (10 μM). DNA was visualized in
blue, pRPB1Ser5 was visualized in red, and Ace-tubulin was visualized in green. Scale bar =
20 μm. B: Immunolocalization of pRPB1Ser5 on chromosomes. Chromosome spreads were made at the
pro-MI, MI and MII stages and processed for immunostaining using antibodies to pRPB1Ser2 and
CREST. pRPB1Ser5 was visualized in red, CREST was visualized in green and DNA was visualized
in blue. Scale bar = 10 μm. pRPB1Ser5 was uniformly distributed along the whole chromosome
structure, with a relatively high concentration in the centromere area.
A: Changes of pRPB1Ser5 distribution in MI oocytes treated with spindle-disturbing agents.
pRPB1Ser5 always remained colocalized with microtubules as spindle integrity and
microtubule stability were altered with nocodazole (10 μM) and taxol (10 μM). DNA was visualized in
blue, pRPB1Ser5 was visualized in red, and Ace-tubulin was visualized in green. Scale bar =
20 μm. B: Immunolocalization of pRPB1Ser5 on chromosomes. Chromosome spreads were made at the
pro-MI, MI and MII stages and processed for immunostaining using antibodies to pRPB1Ser2 and
CREST. pRPB1Ser5 was visualized in red, CREST was visualized in green and DNA was visualized
in blue. Scale bar = 10 μm. pRPB1Ser5 was uniformly distributed along the whole chromosome
structure, with a relatively high concentration in the centromere area.To determine the specific local positioning of pRPB1Ser5 on the chromosome structure in oocytes,
chromosomes spreads were immunolabeled with pRPB1Ser5 antibody and CREST serum. As shown in Fig. 6B, highly concentrated pRPB1Ser5 was persistently
observed on chromosome centromeres at the pro-MI, MI and MII stages (Fig.
6B, b–d, f–h: arrow). A little weaker pRPB1Ser5 signal was also distributed throughout
individual chromosomes. This evidence suggests pRPB1Ser5 may be involved in cellular events
associated with kinetochores, as well as the maintenance of chromosome configuration during oocyte
meiosis.
pRPB1Ser7 was co-localized with spindle microtubules during meiotic division
As shown in Fig. 7, pRPB1Ser7 was highly detected and evenly distributed within the nucleus in NSN-type oocytes
at the GV stage (Fig. 7, c), but rarely observed in SN-type cells
(Fig. 7, c’: arrow). Upon GVBD, pRPB1Ser7 reappeared as
filamentous aggregates in the vicinity around condensing chromatin and co-localized with the emerging
microtubules (Fig. 7, f–h: arrow). Along with oocyte progression to
the MII stage, pRPB1Ser7 had the exactly same distribution pattern as that of microtubules. At two
meiotic metaphases, pRPB1Ser7 fibers were shaped into a bipolar architecture that was precisely
overlapped with the microtubule-organized spindle (Fig. 7, n–p,
v–x). No pRPB1Ser7 was detected on chromosomes from the GVBD to MII stage (data not shown).
In the negative control, no fluorescence signal of pRPB1Ser7 was detected (Supplementary Fig. 1, B).
Fig. 7.
pRPB1Ser7 subcellular localization in mouse oocytes. Immunocytochemical analysis revealed
the dynamic subcellular distribution of pRPB1Ser7 in oocytes during meiotic maturation. DNA
was visualized in blue, pRPB1Ser7 was visualized in red, and Ace-tubulin was visualized in
green. Yellow suggests the overlapping of pRPB1Ser7 and microtubulin. Scale bar = 20 μm.
pRPB1Ser7 was uniformly distributed in the nucleus of NSN-type oocytes (a–d) and rarely
detected in SN oocytes (a’–d’). After oocytes resumed meiosis, chromatin was condensed into individual
chromosomes, and pRPB1Ser5 reappeared as filamentous threads co-localized with microtubules
from the GVBD to MII stage and were typically assembled into a spindle-like structure at the MI and MII
stages, which was completely overlapped with the meiotic spindle organized from microtubules (m–p,
u–x).
pRPB1Ser7 subcellular localization in mouse oocytes. Immunocytochemical analysis revealed
the dynamic subcellular distribution of pRPB1Ser7 in oocytes during meiotic maturation. DNA
was visualized in blue, pRPB1Ser7 was visualized in red, and Ace-tubulin was visualized in
green. Yellow suggests the overlapping of pRPB1Ser7 and microtubulin. Scale bar = 20 μm.
pRPB1Ser7 was uniformly distributed in the nucleus of NSN-type oocytes (a–d) and rarely
detected in SN oocytes (a’–d’). After oocytes resumed meiosis, chromatin was condensed into individual
chromosomes, and pRPB1Ser5 reappeared as filamentous threads co-localized with microtubules
from the GVBD to MII stage and were typically assembled into a spindle-like structure at the MI and MII
stages, which was completely overlapped with the meiotic spindle organized from microtubules (m–p,
u–x).The correlation between pRPB1Ser7 and microtubules was further verified by using
microtubule-targeting drugs. As shown in Fig. 8, pRPB1Ser7 disappeared along with the disassembly of microtubules in MI oocytes treated with
nocodazole, while in taxol-treated oocytes, pRPB1Ser7 underwent the same change pattern as
microtubules, which were stabilized in the spindle and cytoplasmic MTOCs. This evidence suggests that
pRPB1Ser7 is associated with the microtubule polymerization state and might play a role in
spindle formation during both meiotic divisions.
Fig. 8.
Pharmacological verification of the morphological relationship between pRPB1Ser7 and
microtubules in MI oocytes. Changes in pRPB1Ser7 distribution were essentially the same as
those of microtubules in MI oocytes treated with nocodazole (10 μM) and taxol (10 μM). DNA was
visualized in blue, pRPB1Ser7 was visualized in red and Ace-tubulin was visualized in green.
Scale bar = 20 μm.
Pharmacological verification of the morphological relationship between pRPB1Ser7 and
microtubules in MI oocytes. Changes in pRPB1Ser7 distribution were essentially the same as
those of microtubules in MI oocytes treated with nocodazole (10 μM) and taxol (10 μM). DNA was
visualized in blue, pRPB1Ser7 was visualized in red and Ace-tubulin was visualized in green.
Scale bar = 20 μm.
Discussion
It is well known that general genomic transcription becomes silenced when the cell cycle enters mitosis or
meiosis [1, 2], but the fate of the
transcription machine during the subsequent cell division is still not fully clear. We investigated the status
of CTD phosphorylation in mouse oocytes during meiotic maturation and confirmed that CTD phosphorylation
definitely occurred in oocytes after meiotic resumption, which may be involved in spindle formation and
kinetochore function, which are essential for ensuring accurate chromosome separation.There were two different types of chromatin configuration in GV-stage oocytes: NSN or SN nucleolus chromatin
configurations [17]. In NSN-type oocytes, the transcription process is
active and characterized by a DNA-binding functional transcription complex with a hyperphosphorylated CTD, while
in SN-type oocytes, transcription is arrested, the CTD was dephosphorylated and RNAP II and related factors are
detached from the nucleus [14]. However, the phosphorylation pattern of
specific individual amino residues in the CTD sequence during the nuclear transition from the NSN to SN type has
not been determined. In the present study, immunofluorescence analysis revealed that CTD phosphorylation at
Ser2, Ser5 and Ser7 (denoted as pRPB1Ser2, pRPB1Ser5 and pRPB1Ser7,
respectively) was highly detected and uniformly distributed in the nucleus in NSN oocytes but only faintly
detected in SN oocytes. This is logically consistent with the fact that transcription activity was totally shut
down in SN-type oocytes. Immunoblotting analysis detected high levels of pRPB1Ser2 and
pRPB1Ser5 not only at the GV stage but also at stages up to MII. Interestingly, the protein level
of pRPB1Ser7 was significantly increased after meiotic resumption. Therefore, CTD phosphorylation
definitely occurs in oocytes after meiotic resumption when transcription is silenced. RPB1 with a phosphorylated
CTD was not degraded but was transferred from the nucleus to cytoplasm, and it might be involved in regulation
of the meiotic cell cycle.With the progression of the cell cycle from GVBD to MII in mouse oocytes, pRPB1Ser2,
pRPB1Ser5 and pRPB1Ser7 exhibited unique distribution patterns that were not associated
with transcription but related to cellular events responsible for chromosome division. pRPB1Ser2 was
specially co-localized with key MTOC components, γ-tubulin and pericentrin, on the spindle poles. Both
pRPB1Ser5 and pRPB1Ser7 were co-localized with microtubules on the spindle, exhibiting
the same change pattern as microtubules in response to microtubule-targeting drugs. This morphological evidence
implies that CTD phosphorylation may play roles in MTOC organization and functional maturation and may be
required for meiotic spindle formation and maintenance in mouse oocytes.The spindle apparatus works as the direct power driving chromosome segregation, and any structural abnormality
in the spindle can undermine the accuracy of chromosome separation, causing oocyte aneuploidy [18]. In the somatic cell, mitotic spindle formation is controlled by a
functional complex, the centrosome [19]. The mammalian oocyte does not
contain the typical centrosome structure, which is ascribed to the degeneration of centrioles at the early stage
of oogenesis. The meiotic spindle formation is acentrosomal and depends on a unique MTOC [18, 20, 21].
However, the molecular composition and regulatory mechanisms of MTOCs in oocyte meiosis are still not fully
understood [21, 22]. Pericentrin
and γ-tubulin are the core components of MTOCs, and γ-tubulin forms a conical structure known as the γ-tubulin
ring complex (γ-TuRC), which is anchored to the MTOC and catalyzes the assembly of α/β tubulin dimers into
microtubules [23, 24]. Pericentrin
functions as a scaffold for anchoring γ-tubulin and other protein to the MTOC platform [16, 22]. There are some other proteins, especially
some protein kinases, including aurora kinase A (AURKA) [25], polo like
kinase 1(Plk1) [26] and protein kinase C-delta (PKCδ) [27], that join the MTOC structure after meiotic resumption, promoting the
functional maturation of MTOCs. Similar to these regulatory proteins, pRPB1Ser2 was co-localized with
pericentrin and γ-tubulin on spindle poles after GVBD, strongly implying that it is a newly found
MTOC-associated protein, but its exact role in MTOC organization requires further morphological and functional
studies. The functional effectiveness of the spindle depends on its structural integrity, which is tightly
associated with microtubule stability [28]. In the present study,
filamentous aggregates of both pRPB1Ser5 and pRPB1Ser7 were precisely co-localized with
microtubules, indicating that these two proteins might be involved in the regulation of microtubule stability,
and this speculation was further supported by the fact that both pRPB1Ser5 and pRPB1Ser7
responded to spindle-disturbing agents. The multiple types of CTD phosphorylation may regulate different aspects
of meiotic spindle formation in mouse oocytes.Besides the localization on MTOCs, pRPB1Ser2 and pRPB1Ser5 were also persistently
concentrated on centromeres of chromosomes, suggesting that these proteins might be related to the regulation of
spindle microtubule attachment on chromosomes. The kinetochore, a complex structure assembled on each centromere
of the chromatid, acts as the attachment site for spindle microtubules [29]. An unattached kinetochore is actually a platform recruiting spindle assembly checkpoint (SAC)
proteins [30], and the SAC is a supervisory system guaranteeing the
fidelity of chromosome segregation during the process of cell division by initiating a signaling pathway, which
prevents separation of duplicated chromosomes until each chromosome is properly attached to the spindle
apparatus [31, 32]. Currently, the
molecular mechanism of SAC functional regulation is not yet fully understood, especially the recruitment and
disassociation of SAC proteins in kinetochore area [33]. Whether or not
the centromere-localized pRPB1Ser2 and pRPB1Ser5 are involved in SAC regulation requires
further investigation.In summary, RNAP II CTD phosphorylation occurs in oocytes during meiotic division, which is transcription
independent, and might be involved in molecular mechanisms ensuring accurate chromosome separation in multiple
aspects, such as MTOC organization and positioning, spindle formation and maintenance, and SAC functional
regulation.
Authors: Corinna Hintermair; Martin Heidemann; Frederic Koch; Nicolas Descostes; Marta Gut; Ivo Gut; Romain Fenouil; Pierre Ferrier; Andrew Flatley; Elisabeth Kremmer; Rob D Chapman; Jean-Christophe Andrau; Dirk Eick Journal: EMBO J Date: 2012-05-01 Impact factor: 11.598
Authors: Petr Solc; Vladimir Baran; Alexandra Mayer; Tereza Bohmova; Gabriela Panenkova-Havlova; Adela Saskova; Richard M Schultz; Jan Motlik Journal: Biol Reprod Date: 2012-10-11 Impact factor: 4.285